Post-approval studies (Phase 4)Study completedNCT01023724
What this trial is testing
A Comparison of Post Phacoemulsification Aqueous Flare in Patients Using Ketorolac 0.45% 2 Times Daily (BID) and Bromfenac 0.09% 2 Times Daily (BID)
Who this might be right for
Post Operative Anterior Chamber Inflammation (Flare)
Bucci Laser Vision Institute 50